Scott C. Woller

Scott C. Woller, MD

Languages spoken: English, Spanish, Portuguese

Academic Information

Departments Primary - Internal Medicine

Divisions: General Medicine

Board Certification

  • American Board of Internal Medicine (Internal Medicine)

Dr. Woller’s academic interests reside in thrombosis medicine and anticoagulation management. With a particular interest in the prevention of venous thromboembolic disease, Dr. Woller has served as investigator on multiple ongoing and completed clinical trials including the NIH-funded studies. Dr. Woller is Co-Chair for the American College of Chest Physicians (ACCP) Clinical Practice Guideline that addresses antithrombotic therapy for venous thromboembolic disease, and as was a panelist for the Vascular Access Appropriateness Panel housed at the University of Michigan. Dr. Woller is an invited panelist for the Centers for Disease Control and Prevention (CDC) Risk Assessment Model for the Prevention of Venous Thromboembolic Disease in Medical Patients program.

Dr. Woller is Professor of Medicine, University of Utah School of Medicine, Professor in Research, Intermountain Healthcare, and is a recognized teacher and recipient of the Intermountain Medical Center Housestaff Teaching Award (2011), the University of Utah School of Medicine Outstanding Faculty Teaching Award (2012), and the University of Utah Department of Internal Medicine Outstanding Faculty Subspecialty Teaching Award (2021, 2024). Dr. Woller, Fellow of the American College of Chest Physicians (FCCP) and Fellow of the American College of Physicians (FACP), served as Utah Chapter Governor of the American College of Physicians (Class of 2025). Dr. Woller's research group was awarded the 2015 U.S. Centers for Disease Control and Prevention (CDC) Healthcare-Associated Venous Thromboembolism (HA-VTE) Prevention Challenge Award. It was with sincere humility and gratitude that Dr. Woller received the Intermountain Health Patient Experience Award (2022, 2024).

Dr. Woller received his medical degree from Northwestern University Medical School in 2000. Dr. Woller completed his residency at the University of Utah Hospital (2003) then served as Chief Medical Resident in 2003-04. Dr. Woller is Board Certified in Internal Medicine and attends at the Intermountain Medical Center, Murray UT.

Education History

Undergraduate University of Wisconsin - Milwaukee
 BS
Professional Medical Northwestern University Medical School
 MD
Internship University of Utah School of Medicine
 Intern
Residency University of Utah School of Medicine
 Resident
Chief Resident University of Utah School of Medicine
 Chief Resident

Selected Publications

Journal Article

  1. den Exter PL, Woller SC, Robert-Ebadi H, Masias C, Morange PE, Castelli D, Hansen JB, Geersing GJ, Siegal DM, de Wit K, Klok F (2022). Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease. Journal of thrombosis and haemostasis, 20, 1910-1919. (Read full article)
  2. Groat D, Martin KA, Rosovsky RP, Sanfilippo KM, Gaddh M, Kreuziger LB, Eyster ME, Woller SC, Venous thromboEmbolism Network US (VENUS) VTE Treatment, Anticoagulation Management Group (2022). Physician perceptions and use of reduced-dose direct oral anticoagulants for extended phase venous thromboembolism treatment. Research and practice in thrombosis and haemostasis, 6(4), e12740. (Read full article)
  3. Woller SC, Stevens SM, Bledsoe JR, Fazili M, Lloyd JF, Snow GL, Horne B (2022). Biomarker derived risk scores predict venous thromboembolism and major bleeding among patients with COVID-19. Research and practice in thrombosis and haemostasis, 6(5), e12765. (Read full article)
  4. Stevens SM,Fazili M,Woller S (2020). Choosing ultrasound technique for suspected deep vein thrombosis: Which is best?. Quantitative imaging in medicine and surgery, 10(6), 1418-1421. (Read full article)
  5. Kay A,Majercik S,Sorensen J,Woller S,Stevens S,White T,Morris D,Baldwin M,Bledsoe (2018). Weight-based enoxaparin dosing and deep vein thrombosis in hospitalized trauma patients: A double-blind, randomized, pilot study. Surgery, 164(1), 144-149. (Read full article)
  6. Woller S,Bertin K,Stevens S,Jones J,Evans R,Lloyd J,Samuelson K,Hickman J,Hanseen R,Barton S,Aston V,Elliott (2012). A Prospective Comparison of Warfarin to Aspirin for Thromboprophylaxis in Total Hip and Total Knee Arthroplasty. The Journal of arthroplasty, 27(1), 1-9.e2. (Read full article)
  7. Woller SC,Stevens SM,Jones J (2012). Erratum: Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients (American Journal of Medicine (2011) 124 (947-954)). The American journal of medicine, 125(10), (Read full article)
  8. Fiore MC,Hartman M,Mielke M,Strecker E,Woller S,Baker (1996). Raising Wisconsin's tobacco excise fees: Protecting children, increasing revenue, saving lives. Wisconsin medical journal, 95(11), 769-772. (Read full article)
  9. Geersing GJ,Zuithoff P,Kearon C,Anderson D,Ten Cate-Hoek A,Elf J,Bates S,Hoes A,Kraaijenhagen R,Oudega R,Schutgens R,Stevens S,Woller S,Wells P,Moons (2014). Exclude DVT with a clinical decision rule. Huisarts en wetenschap, 57(12), (Read full article)
  10. Kearon C,Spencer FA,O'Keeffe D,Parpia S,Schulman S,Baglin T,Stevens SM,Kaatz S,Bauer KA,Douketis JD,Lentz SR,Kessler CM,Moll S,Connors JM,Ginsberg JS,Spadafora L,Julian JA,Smale S,Winkworth T,Bedek N,Glushchenko A,Gross PL,Linkins LA,O'Donnell M,Weitz J,Conway J,Watts M,Bourke D,Kiely P,Baglin C,Rudd-Scott L,Zondag M,Eikelboom J,Aston VT,Elliott G,Woller SC,Ellsworth S,Gikas H,Ahsan ST,Shah V,Mahony M,Rodrigues A,Zwicker JI,Betz R,Schnurr T,Chan H,Crowther M,Lim W,Peters T,Lammer M,Kaboli P,Leaverton S,MacFarlane D,Jacobs H,Abdallah R,Broome C,Key NS,Kasthuri RS,Jeanneret C,Kellerman R,Naik N,Rowe BS,Stewart L,Wentz R,Berliner N,McCaffrey (2015). D-Dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: A cohort study. Annals of internal medicine, 162(1), 27-34. (Read full article)
  11. Woller SC,Stevens SM,Towner S,Olson J,Christensen P,Hamilton S,Newman L,Mott L,Hu P,Brunisholz KD,Long Y,Lloyd J,Evans RS,Cannon W,Elliott C (2015). The computerized clinical decision support improves warfarin therapy and reduces recurrent venous thromboembolism. Vasomed, 27(3), 146-148. (Read full article)
  12. Bledsoe JR, Knox D, Peltan ID, Woller SC, Lloyd JF, Snow GL, Horne BD, Connors JM, Kline J (2022). D-dimer Thresholds to Exclude Pulmonary Embolism among COVID-19 Patients in the Emergency Department: Derivation with Independent Validation. Clinical and applied thrombosis/hemostasis, 28, 10760296221117997. (Read full article)
  13. Woller SC, de Wit K, Robert-Ebadi H, Masias C, Klok FA, den Exter PL, Morange PE, Castelli D, Hansen J (2022). A systematic review of biomarkers among hospitalized patients with COVID-19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH. Research and practice in thrombosis and haemostasis, 6(6), e12786. (Read full article)
  14. Carmichael HL, Peltan I, Palakanis K, Davis A, Dalto J, Jacobs JR, Rhodes R, Shah M, Webb B, Woller SC, Bledsoe J (2022). Remote biometric monitoring of COVID-19 patients with exertional hypoxia treated with supplemental oxygen. Chest, (Read full article)
  15. Allen-Brady K, Colletier KJ, Woller S, Eliason K, Uchida AM, Ro G, Newman M, Peterson K (2022). Eosinophilic Gastritis and Enteritis Are Increased in Families with Eosinophilic Esophagitis. The American journal of gastroenterology, 118(2), 263-268. (Read full article)
  16. Khairani CD, Bejjani A, Piazza G, Jimenez D, Monreal M, Chatterjee S, Pengo V, Woller SC, Cortes-Hernandez J, Connors JM, Kanthi Y, Krumholz HM, Middeldorp S, Falanga A, Cushman M, Goldhaber SZ, Garcia DA, Bikdeli (2022). Direct Oral Anticoagulants vs Vitamin-K Antagonists in Thrombotic Antiphospholipid Syndrome: Meta-analysis of Randomized Controlled Trials. Journal of the American College of Cardiology, 81, 16-30. (Read full article)
  17. Tesfazghi MT, Bass AR, Al-Hammadi N, Woller SC, Stevens SM, Eby CS, Scott MG, Snyder L, Wildes TS, Gage B (2022). Predicting Postoperative Troponin in Patients Undergoing Elective Hip or Knee Arthroplasty: A Comparison of Five Cardiac Risk Prediction Tools. Cardiology research and practice, 2022, 8244047. (Read full article)
  18. Woller IA, Woller SC, Stevens SM, Lloyd JF, Conner KE, Gordon BH, Snow GL, Jones P, Bledsoe J (2022). Synoptic reporting accuracy for computed tomography pulmonary arteriography among patients suspected of pulmonary embolism. Journal of the American College of Emergency Physicians open, 3(5), e12801. (Read full article)
  19. Bunch TJ, May H, Cutler M, Woller SC, Jacobs V, Stevens SM, Carlquist J, Knowlton KU, Muhlestein JB, Steinberg BA, Anderson J (2022). Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non-valvular atrial fibrillation (cognitive decline and dementia in patients with non-valvular atrial fibrillation [CAF] trial). Journal of arrhythmia, 38(6), 997-1008. (Read full article)
  20. Martin KA, Lancki N, Li C, Eyster ME, Sanfilippo K, Woller IA, Woller SC, Kreuziger LB, Rosovsky R (2023). DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network. Journal of thrombosis and thrombolysis, (Read full article)
  21. Sanchez-Garcia J, Lopez-Verdugo F, LeCorchick S, Tran A, Gilroy RK, Fujita S, Zendejas I, Gagnon A, Dow S, Krong J, Rodriguez-Davalos MI, Stevens SM, Woller SC, Alonso (2023). Performance of a Prospective Anticoagulation Stratification Algorithm After Liver Transplantation. Transplantation direct, 9(3), e1453. (Read full article)
  22. Bledsoe J, Woller SC, Brooks M, Sciurba FC, Krishnan JA, Martin D, Hou P, Lin JY, Kindzelski A, Handberg E, Kirwan BA, Zaharris E, Castro L, Shapiro NL, Pepine CJ, Majercik S, Fu Z, Zhong Y, Venugopal V, Lai YH, Ridker PM, Connors J (2023). Clinically stable covid-19 patients presenting to acute unscheduled episodic care venues have increased risk of hospitalization: secondary analysis of a randomized control trial. BMC infectious diseases, 23(1), 325. (Read full article)
  23. Hyder SN, Han HB, Ash S, Horne BD, Stevens SM, Woller SC, Barnes G (2023). Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers. Thrombosis research, 227, 45-50. (Read full article)
  24. de Jong CMM, de Wit K, Black SA, Gwozdz AM, Masias C, Parks AL, Robert-Ebadi H, Talerico R, Woller SC, Klok F (2023). Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease. Journal of thrombosis and haemostasis, (Read full article)
  25. Kay AB, Morris DS, Woller SC, Collingridge DS, Majercik (2023). Below the knee, let it be: Management of calf DVT in hospitalized trauma patients. American journal of surgery, (Read full article)
  26. Lee Cervi A, Applegate D, Stevens SM, Woller SC, Baumann Kreuziger LM, Punchhalapalli K, Wang TF, Lecumberri R, Greco K, Bai Y, Bolger S, Fontyn S, Schulman S, Foster G, Douketis J (2023). Antithrombotic Management of Patients with Deep Vein Thrombosis and Venous Stents: An International Registry. Journal of thrombosis and haemostasis, (Read full article)
  27. Parks AL, Fazili M, Aston V, Porter TF, Branch DW, Woller SC, Snow GL, Stevens S (2023). Excluding pregnancy-associated deep vein thrombosis with whole-leg ultrasound. Research and practice in thrombosis and haemostasis, 7(7), 102202. (Read full article)
  28. Groat D, Martin KA, Rosovsky RP, Sanfilippo KM, Gaddh M, Baumann Kreuziger L, Federici E, Woller SC, Venous thromboEmbolism Network US (VENUS) VTE Treatment and Anticoagulation Management Grou (2023). Primary Care Clinicians' Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment. Journal of clinical medicine, 13(1), (Read full article)
  29. Parks AL, Stevens SM, Woller S (2024). Anticoagulant therapy in renal insufficiency theme: Anticoagulation in complex situations. Thrombosis research, 241, 109097. (Read full article)
  30. Woller SC, Stevens SM, Bledsoe JR, Hellewell J, Kraft A, Butler AM, Fazili M, Lloyd JF, Christensen PS, Peltan ID, Barnes GD, Horne B (2024). Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent hospital-associated venous thromboembolism. Research and practice in thrombosis and haemostasis, 8(6), 102549. (Read full article)
  31. Kay AB, Morris DS, Woller SC, Stevens SM, Bledsoe JR, Collingridge DS, Jacobs JR, Majercik (2022). The Risk Assessment Profile is suboptimal for guiding duplex ultrasound surveillance in trauma patients. Surgery in practice and science, 11, 100127. (Read full article)
  32. Mishra S, Klok FA, Le Gal G, de Wit K, Schwartz A, Luijten D, Sadeghipour P, Bayley J, Woller S (2025). An assessment of evidence to inform best practice for the communication of acute venous thromboembolism diagnosis: a scoping review. Research and practice in thrombosis and haemostasis, 9(3), 102835. (Read full article)
  33. Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, McCorkell L, Nadkarni GN, Parthasarathy S, Singh U, Walker TA, Selvaggi CA, Shinnick DJ, Schulte CCM, Atchley-Challenner R, Alba GA, Alicic R, Altman N, Anglin K, Argueta U, Ashktorab H, Baslet G, Bassett IV, Bateman L, Bedi B, Bhattacharyya S, Bind MA, Blomkalns AL, Bonilla H, Brim H, Bush PA, Castro M, Chan J, Charney AW, Chen P, Chibnik LB, Chu HY, Clifton RG, Costantine MM, Cribbs SK, Davila Nieves SI, Deeks SG, Duven A, Emery IF, Erdmann N, Erlandson KM, Ernst KC, Farah-Abraham R, Farner CE, Feuerriegel EM, Fleurimont J, Fonseca V, Franko N, Gainer V, Gander JC, Gardner EM, Geng LN, Gibson KS, Go M, Goldman JD, Grebe H, Greenway FL, Habli M, Hafner J, Han JE, Hanson KA, Heath J, Hernandez C, Hess R, Hodder SL, Hoffman MK, Hoover SE, Huang B, Hughes BL, Jagannathan P, John J, Jordan MR, Katz SD, Kaufman ES, Kelly JD, Kelly SW, Kemp MM, Kirwan JP, Klein JD, Knox KS, Krishnan JA, Kumar A, Laiyemo AO, Lambert AA, Lanca M, Lee-Iannotti JK, Logarbo BP, Longo MT, Luciano CA, Lutrick K, Maley JH, Mallett G, Marathe JG, Marconi V, Marshall GD, Martin CF, Matusov Y, Mehari A, Mendez-Figueroa H, Mermelstein R, Metz TD, Morse R, Mosier J, Mouchati C, Mullington J, Murphy SN, Neuman RB, Nikolich JZ, Ofotokun I, Ojemakinde E, Palatnik A, Palomares K, Parimon T, Parry S, Patterson JE, Patterson TF, Patzer RE, Peluso MJ, Pemu P, Pettker CM, Plunkett BA, Pogreba-Brown K, Poppas A, Quigley JG, Reddy U, Reece R, Reeder H, Reeves WB, Reiman EM, Rischard F, Rosand J, Rouse DJ, Ruff A, Saade G, Sandoval GJ, Santana JL, Schlater SM, Sciurba FC, Shepherd F, Sherif ZA, Simhan H, Singer NG, Skupski DW, Sowles A, Sparks JA, Sukhera FI, Taylor BS, Teunis L, Thomas RJ, Thorp JM, Thuluvath P, Ticotsky A, Tita AT, Tuttle KR, Urdaneta AE, Valdivieso D, VanWagoner TM, Vasey A, Verduzco-Gutierrez M, Wallace ZS, Ward HD, Warren DE, Weiner SJ, Welch S, Whiteheart SW, Wiley Z, Wisnivesky JP, Yee LM, Zisis S, Horwitz LI, Foulkes AS, RECOVER Consortiu (2023). Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA, 329(22), 1934-1946. (Read full article)
  34. Shah DP, Thaweethai T, Karlson EW, Bonilla H, Horne BD, Mullington JM, Wisnivesky JP, Hornig M, Shinnick DJ, Klein JD, Erdmann NB, Brosnahan SB, Lee-Iannotti JK, Metz TD, Maughan C, Ofotokun I, Reeder HT, Stiles LE, Shaukat A, Hess R, Ashktorab H, Bartram L, Bassett IV, Becker JH, Brim H, Charney AW, Chopra T, Clifton RG, Deeks SG, Erlandson KM, Fierer DS, Flaherman VJ, Fonseca V, Gander JC, Hodder SL, Jacoby VL, Kotini-Shah P, Krishnan JA, Kumar A, Levy BD, Lieberman D, Lin JJ, Martin JN, McComsey GA, Moukabary T, Okumura MJ, Peluso MJ, Rosen CJ, Saade G, Shah PK, Sherif ZA, Taylor BS, Tuttle KR, Urdaneta AE, Wallick JA, Wiley Z, Zhang D, Horwitz LI, Foulkes AS, Singer NG, RECOVER Consortiu (2025). Sex Differences in Long COVID. JAMA network open, 8(1), e2455430. (Read full article)
  35. Swank Z, Borberg E, Chen Y, Senussi Y, Chalise S, Manickas-Hill Z, Yu XG, Li JZ, Alter G, Henrich TJ, Kelly JD, Hoh R, Goldberg SA, Deeks SG, Martin JN, Peluso MJ, Talla A, Li X, Skene P, Bumol TF, Torgerson TR, Czartoski JL, McElrath MJ, Karlson EW, Walt DR, RECOVER consortium author (2024). Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study. Clinical microbiology and infection, 30(12), 1599-1605. (Read full article)
  36. Klok FA, Woller SC, Schwartz A, Mishra S, Angchaisuksiri P, Bayley J, Habert J, Hernandez-Nino J, Hunter R, Kline JA, Luijten D, MacDur HK, Tazi Mezalek Z, Mburu N, Noble S, Richards T, Rocha ATC, Sadeghipour P, Talerico R, van Vliet LM, de Wit K, Le Gal (2025). Optimising communication to patients with venous thromboembolism: development of a provider toolkit. The Lancet. Haematology, 12(6), e411-e412. (Read full article)
  37. Kay AB, Woller SC, Groat D, Regner JL, Schroeppel TJ, Fontaine GV, Majercik (2025). Use of post-discharge venous thromboembolism prophylaxis in hospitalized trauma patients - survey results of Southwestern surgical Congress and Southeastern surgical Congress members. American journal of surgery, 250, 116491. (Read full article)
  38. Woller SC, Stevens SM, Wylie JD, Layne B, Dong L, Lloyd JF, Momberger N (2025). Standardized Thromboembolism Prophylaxis in Orthopedic Patients to Prevent Venous ThromboEmbolism Study: A Novel Prospectively Validated Electronic Risk Stratification Tool for Elective Hip and Knee Joint Replacement Patients. JB & JS open access, 10(4), (Read full article)
  39. Woller SC, Stevens SM, Bledsoe JR, Bride D, Lloyd JF, Butler A, Fazili M, Horne B (2025). Risk of venous thromboembolism associated with short-term exposure to fine particulate matter (PM(2.5)) and ozone air pollution. Research and practice in thrombosis and haemostasis, 9(7), 103226. (Read full article)
  40. Talerico R, de Wit K, Barco S, Bonorino J, Uil CD, Kraemer CE, Germini F, Iding A, Jones A, Konstantinides S, Masias C, Parks AL, Robert-Ebadi H, Tritschler T, Vedovati MC, Vinson DR, Woller SC, Klok F (2025). Evidence-based risk stratification of patients with acute pulmonary embolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease. Journal of thrombosis and haemostasis, (Read full article)

Review

  1. Woller SC,Stevens SM,Johnson SA,Bledsoe JR,Galovic B,Lloyd JF,Wilson EL,Armbruster B,Evans R (2019). Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis (ARM-DVT): Methods of a prospective single-arm management study. Research and practice in thrombosis and haemostasis, 3(3), 340-348. (Read full article)
  2. Stevens SM, Woller SC, Baumann Kreuziger L, Doerschug K, Geersing GJ, Klok FA, King CS, Murin S, Vintch JRE, Wells PS, Wasan S, Moores L (2024). Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021. Chest, (Read full article)

Letter

  1. Woller S,Stevens (2012). The reply. The American journal of medicine, 125(11), (Read full article)
  2. Martin KA, Lancki N, Kreuziger LB, Li C, Eyster ME, Sanfilippo K, Woller SC, Rosovsky R (2023). DOAC compared with warfarin for VTE in low weight patients: A retrospective cohort study conducted through the VENUS network. Thrombosis research, 229, 146-148. (Read full article)
  3. Groat D, Martin KA, Rosovsky RP, Sanfilippo KM, Gaddh M, Kreuziger LB, Federici E, Woller SC, Venous thromboEmbolism Network US (VENUS) VTE Treatment and Anticoagulation Management Grou (2025). Prescribing preferences for reduced-dose direct oral anticoagulation for extended-phase venous thromboembolism treatment. Thrombosis research, 250, 109338. (Read full article)

Other

  1. Martin KA, Lancki N, Li C, Eyster ME, Sanfilippo K, Woller IA, Woller SC, Kreuziger LB, Rosovsky R (2023). Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network. Journal of thrombosis and thrombolysis, (Read full article)